←Back to Expert Scholars
Translational Medicine / 转化医学ROS1 Fusion Resistance Mechanisms
Dong-Wan Kim
MD, PhD
🏢Seoul National University Hospital🌐South Korea
Professor of Medicine
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dong-Wan Kim is a leading Korean oncologist with expertise in ROS1 and ALK-rearranged lung cancers. His clinical trial contributions have been pivotal in defining optimal sequencing of ROS1-targeted agents. He has advanced molecular diagnostics capabilities across Korean cancer centers.
Share:
🧪Research Fields 研究领域
ROS1 fusions
ALK rearrangements
Precision medicine
Clinical trials Asia
Molecular diagnostics
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Dong-Wan Kim 的研究动态
Follow Dong-Wan Kim's research updates
留下邮箱，当我们发布与 Dong-Wan Kim（Seoul National University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment